Author
Masahiro Nakayama
Also Known As
Ling Ren, M Nakayama, M. NAKAYAMA, M. Nakayama, M.N. Nakayama, MASAHIRO NAKAYAMA, Masafumi Nakayama, Masahiro NAKAYAMA, Masahiro Nakayama, Nakayama, Masahiro
300
Publications
7.7K
Citations
38
H-Index
162
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 26 | 49 | 5.4K |
2 | Health Sciences | 7 | 7 | 263 |
3 | Public Health | 4 | 4 | 226 |
4 | Social Sciences | 3 | 3 | 97 |
5 | Allergy | 2 | 2 | 45 |
Masahiro Nakayama
×
95
Publications
7.1K
Citations
37
H-Index
| Year | Citations | |
|---|---|---|
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study Barbara Burtness, Kevin J. Harrington, Richard Greil, Neoadjuvant TherapyChemotherapy Versus CetuximabMedicinePathologyHead And Neck Cancer | 2019 | 3K |
1996 | 385 | |
2004 | 181 | |
2001 | 177 | |
2004 | 152 | |
2002 | 142 | |
2011 | 110 | |
2002 | 99 | |
2001 | 95 | |
2010 | 94 |
Page 1
Page 1